GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: HTWR
Market Perform $60

HEARTWARE (NASDAQ: HTWR) rated to Market Perform with price target $60 by Northland Capital

Thursday,  Oct 1, 2015  8:25 AM ET by Dave Ficere

Northland Capital rated HEARTWARE
(NASDAQ: HTWR) to Market Perform with price target $60.

HeartWare International, Inc. (HeartWare), formerly HeartWare Limited, along with its subsidiaries, is a medical device company focused on developing small implantable pumps for the treatment of advanced heart failure. The Company?s product, the HeartWare Ventricular Assist System (the HeartWare System), includes a left ventricular assist device (LVAD), related accessories and surgical tools and is designed to provide circulatory support for patients with advanced heart failure. The core of the HeartWare System is a continuous flow blood pump, ventricular assist device (the HVAD Pump), a full-output device capable of pumping up to 10 liters of blood per minute. In January 2009, the HeartWare System received Conformite Europeene (CE) Marking, which allows for commercial sales in Europe and is the subject of an ongoing United States bridge-to-transplant clinical trial under an investigational device exemption (IDE) granted by the Food and Drug Administration of United States (FDA).

Northland Capital



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy